In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Alberto Aimo
Alberto Aimo Alberto Aimo

Sant'Anna School of Advanced Studies, Pisa (Italy)

Specialities : Chronic Heart Failure , Cardiac Magnetic Resonance, Pharmacology and Pharmacotherapy

24 presentations from this speaker

A new mutation causing arrhythmogenic right ventricular cardiomyopathy with atypical presentation

Event : Heart Failure 2019

  • Session : Clinical Case Corner 4 - Have you seen this before? Rare presentations
  • Speaker : A Aimo (Pisa,IT)

Gender differences in plasma levels and prognostic value of NT-proBNP in chronic heart failure

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : A Aimo (Pisa,IT)

Gender differences in plasma levels and prognostic value of NT-proBNP in chronic heart failure

Event : ESC Congress 2019

  • Session : Sex differences in heart failure
  • Speaker : A Aimo (Pisa,IT)

Revisiting the obesity paradox in heart failure: percent body fat as predictor of biomarkers and outcome

Event : Heart Failure 2019

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : A Aimo (Pisa,IT)

A new mutation causing arrhythmogenic right ventricular cardiomyopathy with atypical presentation

Event : Heart Failure 2018

  • Session : Myocardial Disease – Clinical
  • Speaker : A Aimo (Pisa,IT)

Left ventricular ejection fraction and prognosis in chronic heart failure

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Epidemiology, Prognosis, Outcome
  • Speaker : A Aimo (Pisa,IT)

Neurohormonal activation across categories of systolic function in chronic heart failure

Event : ESC Congress 2018

  • Session : Chronic heart failure – pathophysiology and mechanisms
  • Speaker : A Aimo (Pisa,IT)

Neurohormonal function across categories of systolic dysfunction in chronic heart failure

Event : Heart Failure 2018

  • Session : Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography
  • Speaker : A Aimo (Pisa,IT)

Norepinephrine, plasma renin activity and prognosis in chronic systolic heart failure

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Pathophysiology and Mechanisms
  • Speaker : A Aimo (Pisa,IT)

N-terminal fraction of pro-B-type natriuretic peptide vs. clinical risk scores for prognostic stratification in chronic systolic heart failure

Event : Heart Failure 2018

  • Session : Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography
  • Speaker : A Aimo (Pisa,IT)

Effect of sex on reverse remodelling in chronic systolic heart failure

Event : ESC Congress 2017

  • Session : Best Posters in devices in heart failure
  • Speaker : A Aimo (Pisa,IT)

Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure

Event : ESC Congress 2017

  • Session : Heart failure with mid-range and preserved ejection fraction
  • Speaker : A Aimo (Pisa,IT)

Sex, reverse remodeling and prognosis in chronic systolic heart failure

Event : Heart Failure 2017

  • Session : Rapid Fire 5 - Diagnosis - Pathophysiology - Prognosis
  • Speaker : A Aimo (Pisa,IT)

A heart with no legs to run: giant cell myocarditis in a patient with bilateral leg amputation after giant cell vasculitis.

Event : Heart Failure 2016

  • Session : Clinical Case Corner 4: When the heart is burning: cases of inflammatory cardiac involvement - Part I
  • Speaker : A Aimo (Pisa,IT)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are